Evidence map›Paper›PMID 35631467›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Neutrophil Immunomodulatory Activity of Farnesene, a Component of

Igor A Schepetkin, Gulmira Özek, Temel Özek, Liliya N Kirpotina, Andrei I Khlebnikov, Robyn A Klein, Mark T Quinn

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Igor A SchepetkinDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.
Gulmira ÖzekDepartment of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey.ORCID 0000-0001-8908-6098
Temel ÖzekDepartment of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Turkey.ORCID 0000-0003-4251-8783
Liliya N KirpotinaDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.
Andrei I KhlebnikovKizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.ORCID 0000-0002-3022-4510
Robyn A KleinDepartment of Plant Sciences and Plant Pathology, Montana State University, Bozeman, MT 59717, USA.
Mark T QuinnDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0001-8114-5073
Montana State University · USAnadolu University · TRNational Research Tomsk State University · RU

Funding

Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Ann Therese Bertagnolli · 2012 to 2026
$60.0M
Tracking and Evaluation CoreU54GM115371 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI HARMSEN, ALLEN G · 2016 to 2020
$20.9M
NIGMS NIH HHS P20 GM103474NIGMS NIH HHS U54 GM115371NIH HHS GM103474NIH HHS GM115371
6 · The paper itself

Abstract

Despite their reported therapeutic properties, not much is known about the immunomodulatory activity of essential oils present in

Indexed as

anti-inflammatoryArtemisiacalcium fluxchemotaxisessential oilsfarnesenemonoterpeneneutrophil

Identifiers

PMID35631467
PMCPMC9143003
OpenAlexW4281487163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.